Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Neuroendocrine Tumors
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 19 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04696042
- Collaborators
- Samsung Medical Center
- Seoul St. Mary's Hospital
- Severance Hospital
- Seoul National University Bundang Hospital
- Investigators
- Principal Investigator: Changhoon Yoo Asan Medical Center